A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body’s immune system is stimulated by the agent, which is recognized as a foreign body by this immune system. The agent is then destroyed and remembered by the immune system. The vaccine agents are inactivated or killed in different ways to reduce infectivity in order to avoid vaccine infections.

The global inactivated vaccines market is estimated to expand at a significant pace during the forecast period. The rising demand for inactivated vaccines from governments of industrialized and developing countries is a key factor driving the global inactivated vaccines market. Advantages of inactivated vaccines over live attenuated vaccines such as safety, stability, and lack of chances of pathogen reactivation can be passed on to immunocompromised people. These factors are likely to drive the global inactivated vaccines market during the forecast period. Furthermore, prevalence of infectious diseases and rise in awareness among people about immunization are other factors propelling the market. However, stringent government regulations regarding efficacy and safety and lack of supply of vaccines in remote areas are projected to be major restraining factors for the global inactivated vaccines market during the forecast period.

The global inactivated vaccines market can be segmented on the basis of product, method of inactivation, route of administration, and region. Based on product, the market can be divided into viral vaccines and bacterial vaccines. The viral vaccines segment is anticipated to hold a significant share of the global inactivated vaccines market from 2017 to 2025, due to increase in research on viruses and surge in the prevalence of viral diseases. Based on method of inactivation, the market can be divided into solvent detergent method, radiation method, pH concentration, heat inactivation, and others. The solvent detergent method segment is expected to hold a major share of the market between 2017 and 2025, due to operational flexibility offered by this method. Based on route of administration, the market can be divided into oral, subcutaneous, intravenous, and others.

Geographically, the global inactivated vaccines market can be segregated into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global inactivated vaccines market during the forecast period. Surge in investments by governments and high incidence of diseases in the region are a few factors propelling the market in North America. Furthermore, rise in awareness about vaccines, government programs, high health care expenditure are other factors fueling the market in the region. Europe is anticipated to hold a significant share of the global market between 2017 and 2025, due to increase in health care expenditure and surge in R&D activities in the region. The market in Asia Pacific is anticipated to witness rapid growth during the forecast period. Asia Pacific is a highly lucrative market for inactivated vaccines, due to high prevalence of diseases, government-induced national immunization programs, and increasing investments in R&D in the region.

In order to attain a significant position in the global inactivated vaccines market, key players are adopting strategies such as mergers and acquisitions, extensive R&D activities, introduction of cost-effective and efficient vaccine products, and collaborative partnerships. Some of the prominent players operating in the global inactivated vaccines market are Emergent BioSolutions, GlaxoSmithKline plc, Merck & Co., Inc., Seqirus, Sanofi, Valneva SE, Pfizer Inc., and Bharat Biotech.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Inactivated Vaccines Market

Pre Book